Theodrenaline
Structural formula | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||
General | |||||||||||||
Non-proprietary name | Theodrenaline | ||||||||||||
other names |
|
||||||||||||
Molecular formula | C 17 H 21 N 5 O 5 | ||||||||||||
External identifiers / databases | |||||||||||||
|
|||||||||||||
Drug information | |||||||||||||
ATC code | |||||||||||||
Drug class | |||||||||||||
Mechanism of action |
α-adrenoceptor agonist |
||||||||||||
properties | |||||||||||||
Molar mass | 375.38 g mol −1 | ||||||||||||
safety instructions | |||||||||||||
|
|||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Theodrenaline is a drug that is used in fixed combination with cafedrin for the parenteral treatment of a clinically relevant anesthesia-related drop in blood pressure , especially in emergency medicine .
In rapid-onset Theodrenalin mediated by α- adrenoceptors a vasoconstriction . Contractility , blood pressure , heart rate and, to a lesser extent , the cardiac output and the peripheral vascular resistance are increased.
Theodrenaline hydrochloride is used pharmaceutically .
Individual evidence
- ↑ G. Geisslinger et al .: Mutschler drug effects . 11th edition. WVG, Stuttgart 2019, p. 395.
- ↑ Product information Akrinor 200 mg / 2 ml + 10 mg / 2 ml injection solution (ratiopharm GmbH), as of August 2019.
- ↑ External identifiers or database links for theodrenaline hydrochloride: CAS number: 2572-61-4, EC number: 219-920-0, ECHA InfoCard: 100.018.110 , PubChem : 3083768 , ChemSpider : 2340923 , Wikidata : Q27266527 . Molecular formula: C 17 H 22 ClN 5 O 5 . Molar mass: 411.84 g mol −1 .